KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axon Enterprise (AXON) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Axon Enterprise (AXON) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.

  • Axon Enterprise's Cash & Equivalents rose 10483.11% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 10483.11%. This contributed to the annual value of $454.8 million for FY2024, which is 2400.84% down from last year.
  • Latest data reveals that Axon Enterprise reported Cash & Equivalents of $1.4 billion as of Q3 2025, which was up 10483.11% from $615.5 million recorded in Q2 2025.
  • Over the past 5 years, Axon Enterprise's Cash & Equivalents peaked at $1.4 billion during Q3 2025, and registered a low of $147.7 million during Q3 2022.
  • Its 5-year average for Cash & Equivalents is $481.8 million, with a median of $403.9 million in 2024.
  • Per our database at Business Quant, Axon Enterprise's Cash & Equivalents tumbled by 4756.28% in 2022 and then skyrocketed by 17488.95% in 2023.
  • Axon Enterprise's Cash & Equivalents (Quarter) stood at $356.3 million in 2021, then decreased by 0.74% to $353.7 million in 2022, then soared by 69.23% to $598.5 million in 2023, then fell by 24.01% to $454.8 million in 2024, then soared by 213.05% to $1.4 billion in 2025.
  • Its Cash & Equivalents was $1.4 billion in Q3 2025, compared to $615.5 million in Q2 2025 and $1.1 billion in Q1 2025.